Jazz Pharma to buy CBD drugmaker GW Pharma for US$7.2B

Mugglehead
By Jared GnamFeb 4, 2021, 4:11 pm764 ptsHotTop
Shares of GW Pharmaceuticals (Nasdaq: GWPH) climbed over 46 per cent after the cannabinoid drugmaker said Wednesday it will be bought by global pharma firm Jazz Pharmaceuticals (Nasdaq: JAZZ) for US$7.2 billion in cash and stock. The proposed deal is set to be the largest acquisition in the cannabis industry to…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Senator offers timeline for major marijuana bill 67

Texas gov. makes final hour decision on hemp ban 64

Pura Vida! Costa Rica officially starts medical cannabis rollout after years of delays 53

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.